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Nonsurgical treatment of scalp arteriovenous
malformation using a combination of
ultrasound-guided thrombin injection and
transarterial coil embolization
Isao Nishijima, MD, Ryo Ikemura, MD, Masuichi Gushiken, MD, Kazufumi Miyagi, MD, and
Kiyoshi Iha, MD, Okinawa, Japan
Scalp arteriovenous malformations are treated by surgical excision in many patients. We report a patient with a scalp
arteriovenous malformation who was successfully treated by a combination of ultrasound-guided thrombin injection
(UGTI) and transarterial coil embolization. This patient was a 52-year-old man with a subcutaneous mass in the left
retroauricular region. An angiogram showed that the mass was a nidus of arteriovenous malformation. We performed
UGTI after transarterial coil embolization. No recurrence or complication was reported during 2 years of follow-up. This
report describes the advantages of UGTI and the method for complete occlusion of the collateral artery. ( J Vasc Surg
2012;55:833-6.)
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DSoft tissue arteriovenous fistulas occur most commonly
in the scalp. Although only 14% of the body surface area
is in the head, 50% of integument arteriovenous fistulas
occur in this region.1 Patients often complain of pain,
tinnitus, an increase in the size of the arteriovenous malfor-
mation (AVM)mass, hemorrhage, and sometimes, necrosis
of the scalp skin.2-4
Surgical excision is commonly performed for the treat-
ment of scalp AVM.2,3,5 However, the excision is often
associated with excessive blood loss, and sometimes, with
the need for skin reconstruction. In many cases, recurrence
is observed owing to recruitment of collateral supply.2
Preoperative embolization of a scalp AVM facilitates
surgical excision by reducing blood loss.6,7 Barnwell et al8
reported patients with scalp AVMwho received a combined
treatment of injection of a sclerosing material and coil
embolization. Here, we report a patient with a scalp AVM
who was successfully treated by a combination of transar-
terial coil embolization and percutaneous thrombin injec-
tion for occlusion of the collateral artery.
CASE REPORT
A 52-year-old man with a 2-year history of a subcutaneous
mass in the left postauricular region never visited a hospital because
the only clinical symptom caused by the mass was tinnitus, which
did not bother him. The patient accidently scratched the mass
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doi:10.1016/j.jvs.2011.08.013hile washing his head, and it immediately started to bleed.Hewas
ransported to our hospital by ambulance because the pulsating
leeding from the mass did not stop. His hemoglobin level on
rrival was 15.0 g/dL, which dropped to 11.8 g/dL on the
ollowing day. We successfully stopped the bleeding by local
ompression with calcium alginate dressing and a bandage around
he head.
Multidetector-row computed tomography scan revealed a
-cm mass composed of several inflow and outflow vessels at the
ostauricular region (Fig 1). A left external carotid angiogram
evealed that the mass received blood from the occipital artery,
osterior auricular artery, and superficial temporal artery. Hyper-
rophied venous drainage that was rapid filling and emptied only
nto the external carotid vein was via a collateral circulation. This
as a fast-flow lesion composed of a nidus of feeding arteries and
ilated veins. Therefore, the patient was diagnosed as having an
VM according to the International Society for the Study of
ascular Anomalies (ISSVA) classification. The subcutaneous
ass, which caused the bleeding, was a nidus of the AVM. The
nternal carotid artery and vertebral artery were normal.
First, we performed transarterial platinum coil embolization of
he occipital, posterior auricular, and superficial temporal arteries
n the catheterization laboratory. Then, we attempted to throm-
ose the nidus to block the blood supply from the collateral artery.
ltrasound-guided thrombin injection (UGTI) was performed
Fig 2). Thrombin (1000 U/mL) was slowly and continuously
njected under the guidance of color and pulsed Doppler ultra-
ound imaging until the flow in the AVM disappeared completely
Fig 3). The procedure required 2500 units of thrombin.
The patient was discharged on postoperative day 3. The AVM
educed and finally disappeared after the operation. No recurrence
r complication was reported after 2 years of follow-up.
ISCUSSION
Scalp AVM is generally treated by surgical excision.2,3,5he risk of recurrence with preoperative embolization is
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March 2012834 Nishijima et alhigh because of the recruitment of collateral supply.2 How-
ever, preoperative embolization of scalp AVM is useful to
reduce blood loss during surgical excision.6,7 Surgical ex-
cision is often associated with large skin incisions, skin
reconstruction is occasionally necessary, and it may cause
facial nerve injury.2 Therefore, we chose nonsurgical treat-
ment.
Barnwell et al8 reported endovascular treatment of
scalp AVM.8 This treatment involves coil embolization of
the main vessel, followed by injection of embolic agents,
including polyvinyl alcohol particles and liquid adhesives
such as isobutyl-2-cyanoacrylate and N-butyl-2-cyanoacrylate
(NBCA). Barnwell et al8 successfully treated seven patients
with AVM by using liquid embolic agents to occlude the
Fig 1. A, Bleeding of the arteriovenous malformatio
multidetector-row computed tomography volume-rende
located in the left retroauricular region.
Fig 2. Ultrasound-guided thrombin injection.A, Blood
continuously injected under ultrasound guidance. C, Th
injection.collateral supply. rWe used UGTI in our patient to occlude the flow from
he collateral artery. Cope first reported UGTI in 1986.9
e reported four instances of UGTI for pseudoaneurysms,
ncluding common iliac pseudoaneurysm, pseudoaneurysm
upture after femoropopliteal bypass grafting, posttraumatic
bular artery pseudoaneurysm, and hepatic pseudoaneurysm
fter percutaneous transhepatic cholangiodrainage. Taking
nto account the general status of all the patients in their
eport, surgical repair was considered highly invasive.
After Liau et al10 reported UGTI for iatrogenic pseu-
oaneurysm of the femoral artery, many subsequent studies
eported the same. According to Sheiman and Brophy,11
4 patients underwent UGTI for iatrogenic pseudoaneu-
ysm of the femoral artery in 2001, with an initial success
s successfully stopped by local compression. B, The
age shows the nidus of the arteriovenous malformation
to the nidus was restricted. B, Thrombin was slowly and
us formation was observed in the nidus after thrombinn wa
red imflow
rombate of 92.6% and a complication rate of 0%. Krueger et al12
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Volume 55, Number 3 Nishijima et al 835assessed the outcomes of 240 patients who underwent
UGTI for iatrogenic pseudoaneurysm of the femoral and
brachial arteries and showed that the initial success rate was
93.8%, the secondary success rate was 99.6%, and the
complication rate was 0.8%. Complications in their report
included one patient with reduced dorsalis pedis artery flow
and one patient with allergic fever. Dorsalis pedis artery
flow was restored the next day, and the allergic fever also
disappeared promptly. No severe complications, such as
arterial thrombosis, were noted. Saad et al13 overviewed
treatment for pseudoaneurysms and recommended percu-
taneous coil embolization and injection of thrombin or
glue when surgical intervention seems difficult for some
reason.13
Many successful UGTI cases have been reported.14-17
Therefore, we thought thrombin might be used for em-
bolic agents as well as NBCA or ethylene-vinyl alcohol
copolymer (Onyx; ev3 Neurovascular, Irvine, Calif).
Because thrombin requires few seconds to induce
thrombosis, thrombin injection therapy is not efficient for
occluding rapid blood flow in an aneurysm but can only
restrict blood flow in a pseudoaneurysm. Thrombin alone is
not sufficient to completely occlude a nidus of an AVM
owing to the rapid blood flow in the nidus. In our patient,
we first reduced the blood flow to the nidus by transarterial
coil embolization of the main inflow vessels and then
performed UGTI. Within the nidus, the thrombus induced
by thrombin occluded the collateral artery. Therefore, the
AVM disappeared completely. If the AVM is not easily
accessible with percutaneous ultrasound guidance, trans-
Fig 3. Left external carotid angiogram shows that after the ultra-
sound-guided thrombin injection, blood flow in the arteriovenous
malformation was completely occluded.catheter thrombin injection may be used.NBCA may cause neurologic deficits and bleeding
omplications in intracranial AVMs.18 Skin necrosis was
eported in the craniofacial region after injection of
BCA.19 We consider that thrombin is safer than NBCA
or inducing thrombosis because if leakage into the sys-
emic circulation occurs, antithrombin III is a thrombin-
eutralizing factor that can abolish the clotting effect of
hrombin.20 We prevented extension of the clot by stop-
ing the thrombin injection when the ultrasound imaging
howed the flow in the AVM disappeared.
As with NBCA, using thrombin as an embolic agent
ay be followed by recurrence of the AVM. Some ablative
gents are used for treatment of AVM. The most com-
only used agents are hypertonic saline, sodium tetradecyl,
nd ethanol, which are used to ablate abnormal endothelial
nd smooth muscle cell. But these ablative agents, espe-
ially ethanol, carry complications of pain, skin necrosis,
nd nerve injury.
ONCLUSIONS
Because it is not possible to completely avoid recurre-
ce of AVM, no matter what method is chosen—including
hrombin, ethanol, or surgical excision—what is the best way
o treat AVM for patients? We conclude that a combination
f UGTI and transarterial coil embolization is a minimally
nvasive treatment for scalp AVM that overcomes the need
or surgical excision.
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